http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84#Head http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84#assertion http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84#provenance http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84#pubinfo http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84#assertion http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT http://www.w3.org/2000/01/rdf-schema#label in tocilizumab recipients 20/34 , 58.82 % than the controls 4/31 , 12.90 % http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE http://www.w3.org/2000/01/rdf-schema#label recorded http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT http://www.w3.org/2000/01/rdf-schema#label More mild temporary adverse events http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84#provenance http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84#_assertion http://www.w3.org/ns/prov#wasGeneratedBy S&T TWOC Project - version 4 http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84#assertion http://www.w3.org/ns/prov#generatedAtTime 2023-06-14T08:54:25.945545 http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0003-4692-1377 http://www.w3.org/2000/01/rdf-schema#ABSTRACT-UID http://www.w3.org/2000/01/rdf-schema#label 3d1w07zy http://www.w3.org/2000/01/rdf-schema#TRIPLE-UID http://www.w3.org/2000/01/rdf-schema#label 3d1w07zy-TRIPLE-ABSTRACT-11 http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84#pubinfo http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84#sig http://purl.org/nanopub/x/hasPublicKey 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 http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84#sig http://purl.org/nanopub/x/hasSignature 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 http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84 http://purl.org/np/RAtlcPrYnHumpdQF7ZpFQVxJw2wB7bgggZexYsj9Gbg84 http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0003-4692-1377